Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Allogenic Hepatocyte Transplantation Into Periduodenal Lymph Nodes — Stella

Home/End Stage Liver Disease/Allogenic Hepatocyte Transplantation Into Periduodenal Lymph Nodes

View on ClinicalTrials.gov

Recruiting

Back to End Stage Liver Disease trials

Allogenic Hepatocyte Transplantation Into Periduodenal Lymph Nodes

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

United States

Tufts Medical Center, Boston, Massachusetts

Houston Methodist Hospital, Houston, Texas

Key details

Phase

Safety & dosing

Sponsor

LyGenesis, Inc.

Enrollment target

~12 participants

Started

March 2022

Primary completion

August 2027

Age range

18 Years – 70 Years

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.